I just fell down a rabbit hole reading about Mikhail Blagosklonny's work and it's completely changed how I think about getting older. His hyperfunction theory of aging, which frames it as an over-activation of growth pathways, makes so much sense.
It all centers on the mTOR pathway. The idea that a drug like Rapamycin could slow aging by briefly inhibiting this pathway is fascinating. It feels like one of the most promising, science-backed avenues for longevity I've come across.
I found a great resource that breaks down his theories in a way that finally clicked for me. You can check out the article I read here.
Is anyone else here looking into mTOR inhibition? I'd love to hear your thoughts or if you have other good sources to recommend.
The connection between Rapamycin and aging is truly fascinating, especially through the lens of Mikhail Blagosklonny’s hyperfunction theory, which views aging as the over-activation of growth pathways like mTOR. The idea that Rapamycin can potentially slow aging by temporarily inhibiting this pathway opens up one of the most promising, science-backed approaches to longevity. Many researchers and enthusiasts are exploring mTOR inhibition as a way to extend healthy lifespan, and there are several excellent resources that break down these concepts in an accessible way. Just as tmregistration simplifies and secures online processes efficiently, diving into these studies can make complex aging research more approachable and actionable for anyone interested in longevity science.
That’s a great rabbit hole to fall into—Blagosklonny’s hyperfunction theory and the idea that aging is driven by continued, unnecessary activation of growth pathways really does make the mTOR–Rapamycin connection feel much more intuitive, and it’s exciting to see how much serious research is building around intermittent mTOR inhibition; while Rapamycin is still being studied and definitely not something to self-experiment with casually, the broader scientific conversation about how cellular growth, repair, and resource allocation shift over time is genuinely fascinating, and I’ve seen several researchers highlight similar mechanisms in longevity papers (some summaries even use simple analogies, like how you’d break down numbers de porcentaje to understand proportional effects); if you’re looking to explore more, reviews on mTOR signaling, hormesis, and nutrient-sensing pathways (AMPK, sirtuins, IGF-1) are great places to expand the discussion without getting into medical territory.
It's a pity that I hvae no idea about mTOR inhibition. Hope that others can help you. Racing Limits
When you reach a certain threshold in Italian Brainrot Clicker, you Prestige to get permanent rewards and start a new, stronger round.